Skip to main content
Equibles
MRK logo

MRK · Merck & Co., Inc. · Metrics

Track MRK — free

Use MRK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MRK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$145.17 +0.46 (+0.32%)
S&P 500 member Russell 1000 member Dow 30 member Rebalance outlook locked
Market Cap
$357.02B
Shares
2.47B

MRK metrics

89 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$144.71
Market cap
$357.02B

Price action

20 metrics
Price change (1W)
-2.7%
Price change (30D)
+13.1%
Price change (3M)
+23.9%
Price change (6M)
+27.0%
Price change (YTD)
+40.2%
Price change (1Y)
+74.4%
Trailing year
Price change (5Y)
+99.9%
52-week high
$156.45
52-week low
$77.60
Change from 52-week high
-5.7%
Change from 52-week low
+90.1%
Annualized volatility
30.7%
Annualized volatility (3M)
37.1%
Beta
0.2
RSI (14D)
56.9
Price vs SMA 50
+9.0%
Price vs SMA 200
+24.1%
Avg volume (3M)
10.50M
Relative volume
0.8
Average dollar volume
$1.39B

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
2.47B

Valuation

12 metrics
P / E (TTM)
118.0
Trailing earnings · reciprocal yield 0.8%
PEG ratio
—
EV / revenue
6.2×
reciprocal yield 16.1%
EV / EBITDA
—
EV / EBIT
—
P / sales
5.5×
reciprocal yield 18.2%
P / book
8.7
reciprocal yield 11.5%
FCF yield
4.4%
TTM · current market cap
Buyback yield
1.1%
P / FCF
22.8
reciprocal yield 4.4%
P / operating cash flow
18.3
reciprocal yield 5.5%
Earnings yield
0.9%

Historical valuation

8 metrics
P / E historical average (3Y)
111.5×
reciprocal yield 0.9%
P / E historical average (5Y)
81.7×
reciprocal yield 1.2%
EV / revenue historical average (3Y)
4.7×
reciprocal yield 21.1%
EV / revenue historical average (5Y)
4.7×
reciprocal yield 21.4%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
2.3%
Trailing 12 months
Payout ratio
261.5%
Shareholder yield
3.4%
Dividend / share (TTM)
$3.36
Dividend growth YoY
+5.0%
Dividend growth streak
5
Last ex-dividend
2026-06-15

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
73.0%
Operating margin
—
Trailing 12 months
Net margin
4.8%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$3.17B
Trailing 12 months
Diluted EPS (TTM)
$1.25
FCF margin
24.1%
Effective tax rate
46.7%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$7.51

Growth

11 metrics
Revenue growth YoY
+5.1%
Year over year
Net income growth YoY
-130.2%
Revenue (TTM)
$66.57B
Trailing 12 months
EPS growth YoY
-130.7%
Shares change YoY
-1.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+3.1%
Revenue CAGR (5Y)
+9.4%
EPS CAGR (3Y)
+8.4%
EPS CAGR (5Y)
+21.2%
FCF CAGR (3Y)
-5.6%
FCF CAGR (5Y)
+16.2%

Quality

14 metrics
Return on equity
7.6%
Return on assets
2.4%
Debt / equity
1.3
Current ratio
1.3
EBITDA (TTM)
—
Free cash flow (TTM)
$16.06B
Quick ratio
1.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$46.77B
Latest balance sheet
Cash & equivalents
$6.85B
Total assets
$129.80B
Total debt
$53.91B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$19.97B
Capital expenditures (TTM)
$3.90B
R&D (TTM)
$30.45B
SG&A (TTM)
$11.14B
Stock compensation (TTM)
$892.00M
R&D / revenue
45.7%
Stock compensation / revenue
1.3%

Ownership (13F)

3 metrics
13F filers
3,799
13F filer change QoQ
-18
Institutional ownership
81.8%

Short interest

3 metrics
Short interest
1.2%
Latest settlement · 2.2 days to cover
Days to cover
2.2d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$29.98M
Insider-sentiment score
19 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 310158 CUSIP 58933Y105 13F (30d) 1022 filings 964 filers Visit website Investor relations